Aligos Therapeutics

ALGS

NASDAQHealth Care

Income Statement

Total Revenue$3.95M

Gross Profit$3.95M

Operating Income$-89.15M

EBITDA$-147.04M

EBIT$-149.66M

Pre-tax Income$-23.88M

Net Income$-131.21M

Cash Equivalent$35.52M

Total Debt$9.46M

Book Value$37.04M

Book Value Per Share11.45

Return on Equity (ROE)-95.22%

Return on Assets (ROA)-187.19%

Return on Invested Capital (ROI)-94.97%

Net Profit Margin-3326.01%

Current Ratio2.86

Quick Ratio2.86

Long-Term Debt / Equity0.00